Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Jilin Anrui Health Technology Co., Ltd., established on 2018-03-26, Business scope includes biological,Technology development in the medical field,technical consulting,technology transfer,Technical Services,Health Information Consultation,Medical Information Consultation,Biological product(In addition to vaccines),Medical device research and development,Sales,Equipment,Wujinjiaodian,electronic product,stationery,Instrumentation,Computer hardware and software and auxiliary equipment,Chemical Products(Removal of hazardous chemicals and precursor drugs)Sales,Software development,import and export trade(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)*

Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany.

Universal Sequencing Technology Corp. (doing business as UST Corporation) is a private company headquartered in Canton, MA. The firm engages in developing DNA sequencing technology. It was founded by Ming Lei, he is the current CEO of the firm.\nThe company says this about itself: Universal Sequencing Technology was established by a group of NGS technology veterans. UST is dedicated to the development of the most advanced, cost-effective, long-read, DNA sequencing technologies. Currently, UST has filed a total of 25 provisional patent applications covering linked long-read library preparation chemistry, single cell sequencing cell capture and library preparation chemistry and groundbreaking 3rd generation DNA sequencing technology. UST is poised to lead the next wave of DNA sequencing innovations.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Ruiyang (Suzhou) Biotechnology Co., Ltd., established on 2015-04-08, Business scope includes research and development of small molecule protein drugs,And provide technical advice,Technology Transfer and Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.

The Research Authority serves as the administrative and financial framework for research activities, scientific experiments and technical analyses carried out by Technion faculty, and TRDF staff. The missions of the Research & Development Division are: - Location, collection, processing and distribution of information concerning local and international research funding - Assistance in locating appropriate funding sources for Technion researchers - R&D information management services and in-campus marketing - Guidance and administrative services for Technion researchers in submitting research proposals to granting agencies and business entities - Management of contractual engagements with granting agencies and business entities - Contractual and budgetary administration of research grants and other accounts

Part of Tasly Pharmaceutical Group Co., Ltd., Shanghai Tasly Pharmaceutical Co. Ltd. is a Chinese company located in Shanghai. The firm manufactures and sells pharmaceutical products. Tasly Pharmaceutical Group Co., Ltd. acquired Shanghai Tasly Pharmaceutical Co. Ltd. on July 12, 2007 for $1.53 million.

Shanghai Academy of Agricultural Science is a private company headquartered in Shanghai, China, that provides agricultural research services.

Shanghai Turing Intelligent Computing Quantum Tech Co., Ltd. is a Chinese company located in Shanghai. The firm operates comprehensive technology innovation company that cross-fuses quantum physics with photonic information, cloud computing, big data and artificial intelligence. It was founded by Xian Min Jin, he is the current CEO of the firm.

Guangzhou Shibao Biotechnology Co., Ltd., established on 2014-05-31, Business scope includes new material technology transfer services;New material technical consultation,communication service;New material technology development service;Biotechnology Transfer Services;Biotechnology Consulting,communication service;Biotechnology Development Services;Agricultural Technology Consulting,communication service;Agricultural Technology Development Services;Agricultural technology extension service;Materials Science Research,technology development;Food Science and Technology Research Services;Agricultural Science Research and Experimental Development;Research and development of biological products(Does not include licensed operations)

Beijing Wanda Yin Biomedical Technology Co., Ltd., established on 2003-07-18, Business scope includes technology development,Technology Promotion,technical consulting,Technical Services,technology transfer;Sales instrumentation,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),medical instrumentsIkind;Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)(After receiving this license,Should be filed with the Commerce Commission;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Tongwei Co. Ltd. engages in agriculture, forestry, livestock husbandry and fishery. It focuses on the production and sales of fish feed, swine feed, poultry feed and fresh water and seawater aquaculture feed. The company was founded on December 8, 1995 and is headquartered in Chengdu, China.

Tempus Labs, Inc. enagegs in the development of a platform that analyzes clinical and molecular data points focusing on cancer research. It connects physicians treatment options and relevant insights for patients based on their unique molecular profile and analytics and machine-learning algorithms. The firm offers genomic sequencing, clinical data structuring, image recognition, biological modeling, and time trial program. The company was founded by Bradley A. Keywell and Eric P. Lefkofsky in 2015 and is headquartered in Chicago, IL.

Sanofi Pasteur SA develops, manufactures, and supplies vaccines in France and internationally. The company provides vaccines for bacterial and viral diseases, including pertussis, diphtheria, typhoid fever, poliomyelitis, influenza, and mumps. It has production sites in France, the United States, Canada, China, Thailand, and Argentina. The company was formerly known as Aventis Pasteur S.A. and changed its name to Sanofi Pasteur SA in 2004. The company was founded in 1990 and is headquartered in Lyon, France. The company is headquartered in Lyon, France. Sanofi Pasteur SA operates as a subsidiary of Sanofi-Aventis.

Jiangsu Jingsen Biomedical New Material Technology Co., Ltd., established on 2010-06-13, Business scope includes biomedical new materials and products,medical supplies,hygiene products,cosmetic,food research and development,technology transfer,Technical Consulting and Technical Services;Biological reagents for scientific research(medicine,Hazardous chemicals excluded)R & D and sales;food business(Subject to the items listed in the food business license);biochemical products(medicine,Hazardous chemicals excluded),medical instruments(limit<Medical Device Business License>Approved scope),hygiene products,sales of cosmetics;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:food production;Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Manufacturing of bio-based materials;Sales of bio-based materials;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)